Advanced Photonix, Inc. acquires Silonex, Inc.

Advanced Photonix, Inc. (NYSE MKT: API), a leading supplier of opto-electronic components, sub-systems and systems to industry, announced March 4, 2013 that it has acquired certain assets of Silonex, Inc. Read more.

New Products

Advanced Photonix Canada, Inc. is helping our clients meet the challenge of rapid product development and shorter product design cycles by increasing the pace of new product development. Bookmark this page to keep current with new ideas and products from Advanced Photonix Canada, Inc.

Audiohm NSL-37-V5C1

Professional audio equipment requires top-quality opto-electronic components. Advanced Photonix Canada, Inc.'s new NSL-37-V5C1 is a cost-effective alternative to industry-standard devices currently used in high-end audio equipment.

Arsuf Electronics appointed as distributor in Israel

Advanced Photonix Canada, Inc. is pleased to announce that Arsuf Electronics has been appointed as a non-exclusive distributor in Israel. This will increase Advanced Photonix Canada, Inc.'s presence in Israel and reduce delivery times for local customers.

Arsuf is an opto-electronics products Distributor/Rep. focused on the Aerospace, Security & Industrial Controls markets. They provide local assistance to the very active R&D community in Israel.

Advanced Photonix Canada, Inc. has a new home

Advanced Photonix Canada, Inc. has moved to downtown Montreal. Visitors will enjoy the charming ambiance of Montreal's Old Port district. The central location is well served by commuter service and local transit which increases the ability to attract top talent.

Please update your address books with the new mailing address. The telephone, fax and e-mail are unchanged.

RoHS

Advanced Photonix Canada, Inc. Request for exemption.

Support for Marshall RoHS exemption request for cadmium in optocouplers.

CdS/CdSe users can request an RoHSExemption.

Prior to May 2006 users of CdS/CdSe products were able to request an RoHS exemption to the prohibition starting July 2006.

This public review process was critical to ensuring that manufacture of products with no viable alternative to CdS/CdSe was able to continue past July 2006.